A founder haplotype of APOE-Sendai mutation associated with lipoprotein glomerulopathy

Journal of Human Genetics

Volumn 58, Issue 5, 2013, Pages 254-258

  Toyota, Kentaro ^a   Hashimoto, Taeko ^a   Ogino, Daisuke ^a   Matsunaga, Akira ^a   Ito, Minoru ^b   Masakane, Ikuto ^c   Degawa, Noriyuki ^d   Sato, Hiroshi ^e   Shirai, Sayuri ^f   Umetsu, Kazuo ^a   Tamiya, Gen ^a   Saito, Takao ^g   Hayasaka, Kiyoshi ^a  

^a YAMAGATA UNIVERSITY   (Japan)

^b Yabuki Hospital   (Japan)

^c Yabuki Shima Clinic   (Japan)

^d Yamagata City Hospital Saiseikan   (Japan)

^e TOHOKU UNIVERSITY   (Japan)

^f ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g FUKUOKA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

APOE; APOE Sendai; lipoprotein glomerulopathy

Indexed keywords

APOLIPOPROTEIN E; GENOMIC DNA;

ACUTE HEART FAILURE; ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CHRONIC GLOMERULONEPHRITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; EPIGENETICS; EXON; FEMALE; GENE FREQUENCY; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GLOMERULOPATHY; HAPLOTYPE; HEMODIALYSIS; HETEROZYGOTE; HUMAN; JAPANESE; KIDNEY BIOPSY; KIDNEY POLYCYSTIC DISEASE; LIPOPROTEIN GLOMERULOPATHY; MALE; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; PATHOGENESIS; SCHOOL CHILD; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; URINARY TRACT MALFORMATION;

ADOLESCENT; ADULT; AGED; APOLIPOPROTEINS E; CHILD; DNA MUTATIONAL ANALYSIS; FEMALE; FOUNDER EFFECT; GENE ORDER; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; JAPAN; KIDNEY DISEASES; MALE; MIDDLE AGED; MUTATION; PEDIGREE; POLYMORPHISM, SINGLE NUCLEOTIDE; RENAL DIALYSIS; YOUNG ADULT;

EID: 84878531950     PISSN: 14345161     EISSN: 1435232X     Source Type: Journal    
DOI: 10.1038/jhg.2013.8     Document Type: Article

References (24)

1. Saito, T., Matsunaga, A. & Oikawa, S. Impact of lipoprotein glomerulopathy on the relationship between lipids and renal diseases. Am. J. Kidney Dis 47, 199-211 (2006).
2. Saito, T., Sato, H., Kudo, K., Oikawa, S., Shibata, T., Hara, Y. et al. Lipoprotein glomerulopathy: glomerular lipoprotein thrombi in a patient with hyperlipoproteinemia. Am. J. Kidney Dis. 13, 148-153 (1989).
3. Oikawa, S., Matsunaga, A., Saito, T., Sato, H., Seki, T., Hoshi, K. et al. Apolipoprotein E Sendai (arginine 145-proline): a new variant associated with lipoprotein glomerulopathy. J. Am. Soc. Nephrol. 8, 820-823 (1997).
4. Tsimihodimos, V. & Elisaf, M. Lipoprotein glomerulopathy. Curr. Opin. Lipidol. 22, 262-269 (2011).
5. Matsunaga, A., Furuyama, M., Hashimoto, T., Toyota, K., Ogino, D. & Hayasaka, K. Improvement of nephrotic syndrome by intensive lipid-lowering therapy in a patient with lipoprotein glomerulopathy. Clin. Exp. Nephrol 13, 659-662 (2009).
6. Hashimoto, T., Toyota, K., Ogino, D., Matsunaga, A. & Hayasaka, K. A second pediatric patient with lipoprotein glomerulopathy carrying a heterozygous APOE-Sendai mutation. Jpn. J. Pediatr. Nephrol. 24, 218-223 (2011).
7. Tokura, T., Itano, S., Kobayashi, S., Kuwabara, A., Fujimoto, S., Horike, H. et al. A novel mutation ApoE2 Kurashiki (R158P) in a patient with lipoprotein glomerulopathy. J. Atheroscler. Thromb. 18, 536-541 (2011).
8. Mitani, A., Ishigami, M., Watase, K., Minakata, T. & Yamamura, T. A novel apolipoprotein E mutation, ApoE Osaka (Arg158 Pro), in a dyslipidemic patient with lipoprotein glomerulopathy. J. Atheroscler. Thromb. 18, 531-535 (2011).
9. Liao, M. T., Tsai, I. J., Cheng, H. T., Lin, W. C., Chang, Y. W., Lin, Y. H. et al. A rare cause of childhood-onset nephrotic syndrome: lipoprotein glomerulopathy. Clin. Nephrol. 78, 237-240 (2012).
10. Ieiri, N., Hotta, O. & Taguma, Y. Resolution of typical lipoprotein glomerulopathy. Am. J. Kidney. Dis. 41, 244-249 (2003).
11. Arai, T., Yamashita, S., Yamane, M., Manabe, N., Matsuzaki, T., Kiriyama, K. et al. Disappearance of intraglomerular lipoprotein thrombi and marked improvement of nephrotic syndrome by bezafibrate treatment in a patient with lipoprotein glomerulopathy. Atherosclerosis 169, 293-299 (2003).
12. Nomachi, S., Tagami, Y., Nakazawa, E., Midzushima, Y., Ozaki, T., Fujita, K. et al. Genetic diagnostic scheme for adult-onset type 2 citrullinemia using dried blood samples. Annu. Rep. Sapporo City Institute Public Health 30, 41-46 (2003).
13. Fullerton, S. M., Clark, A. G., Weiss, K. M., Nickerson, D. A., Taylor, S. L., Stengârd, J. H. et al. Apolipoprotein E variation at the sequence haplotype level: implications for the origin and maintenance of a major human polymorphism. Am. J. Hum. Genet. 67, 881-900 (2000).
14. Sam, R., Wu, H., Yue, L., Mazzone, T., Schwartz, M. M., Arruda, J. A. et al. Lipoprotein glomerulopathy: a new apolipoprotein E mutation with enhanced glomerular binding. Am. J. Kidney Dis. 47, 539-548 (2006).
15. Luo, B., Huang, F., Liu, Q., Li, X., Chen, W., Zhou, S. F. et al. Identification of apolipoprotein E Guangzhou (arginine 150 proline), a new variant associated with lipoprotein glomerulopathy. Am. J. Nephrol. 28, 347-353 (2008).
16. Bomback, A. S., Song, H., D'Agati, V. D., Cohen, S. D., Neal, A., Appel, G. B. et al. A new apolipoprotein E mutation, apoE Las Vegas, in a European-American with lipoprotein glomerulopathy. Nephrol. Dial. Transplant. 25, 3442-3446 (2010).
17. Russi, G., Furci, L., Leonelli, M., Minnei, F., Magistroni, R., Romano, N. et al. Lipoprotein glomerulopathy treated with LDL-apheresis (Heparin-induced extracorporeal lipoprotein precipitation system.): a case report. J. Med. Case Rep 3, 9311 (2009).
18. Matsunaga, A., Sasaki, J., Komatsu, T., Kanatsu, K., Tsuji, E., Moriyama, K. et al. A novel apolipoprotein E mutation, E2 (Arg25Cys), in lipoprotein glomerulopathy. Kidney Int. 56, 421-427 (1999).
19. Ogawa, T., Maruyama, K., Hattori, H., Arai, H., Kondoh, I., Egashira, T. et al. A new variant of apolipoprotein E (apo E Maebashi) in lipoprotein glomerulopathy. Pediatr. Nephrol. 14, 149-151 (2000).
20. Rovin, B. H., Roncone, D., Mckinley, A., Nadasdy, T., Korbet, S. M. & Schwartz, M. M. APOE Kyoto mutation in European Americans with lipoprotein glomerulopathy. N. Engl. J. Med. 357, 2522-2524 (2007).
21. Foster, K., Matsunaga, A., Matalon, R., Saito, T., Gallo, G., Agati, V. D. et al. A rare cause of posttransplantation nephrotic syndrome. Am. J. Kidney Dis. 45, 1132-1138 (2005).
22. Konishi, K., Saruta, T., Kuramochi, S., Oikawa, S., Saito, T., Han, H. et al. Association of a novel 3-amino acid deletion mutation of apolipoprotein E (Apo E Tokyo) with lipoprotein glomerulopathy. Nephron 83, 214-218 (1999).
23. Han, J., Pan, Y., Chen, Y., Li, X., Xing, G., Shi, J. et al. Common apolipoprotein E gene mutations contribute to lipoprotein glomerulopathy in China. Nephron Clin. Pract. 114, c260-c267 (2010).
24. Frommer, M., McDonald, L. E., Millar, D. S., Collis, C. M., Watt, F., Grigg, G. W. et al. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc. Natl Acad. Sci. USA 89, 1827-1831 (1992).